Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075216 | SCV001240830 | likely pathogenic | Retinal dystrophy | 2018-11-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001862601 | SCV002231958 | pathogenic | not provided | 2023-04-29 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with KIZ-related conditions. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 866866). This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Gln467Glyfs*11) in the KIZ gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KIZ are known to be pathogenic (PMID: 24680887, 29057815). |